Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris limited - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris limited - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans - metformin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris limited - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin

Europeiska unionen - svenska - EMA (European Medicines Agency)

biocodex - stiripentol - myoclonic epilepsy, juvenile - antiepileptika, - diacomit är indicerat för användning tillsammans med klobazam och valproat som tilläggsbehandling vid refraktära generaliserade tonisk-kloniska anfall hos patienter med svår myoklonisk epilepsi i barndomen (smei, dravetss syndrom) vars anfall inte är tillräckligt kontrolleras med klobazam och valproat.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Europeiska unionen - svenska - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningit, meningokock - vacciner - nimenrix är indicerat för aktiv immunisering av individer från 6 års ålder mot invasiva meningokocksjukdomar orsakade av neisseria meningitidis grupp a, c, w-135 och y.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Europeiska unionen - svenska - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

krka sverige ab - amoxicillintrihydrat; kaliumklavulanat - filmdragerad tablett - 500 mg/125 mg - kaliumklavulanat 148,9 mg aktiv substans; amoxicillintrihydrat 573,892 mg aktiv substans - amoxicillin och enzymhämmare